Skip to main content
. 2018 Jan 3;9(10):9061–9072. doi: 10.18632/oncotarget.23886

Figure 4. Various explorations conducted in Mouse 14.

Figure 4

Bioluminescence imaging (A), maximum intensity projections of 18F-FDG-PET and CT imaging (B), maximum intensity projections of PET and CT imaging with 64Cu-TE2A-9E7.4 at 2h post-injection (PI) (C) and 24 h PI (D) showing uptakes in the skull, sacrum and left iliac wing (Tumors are indicated by arrows).